Podcasts about Bioethics

Rebecca Bloom is a former employee benefits and executive compensation attorney who spent more than 25 years helping women navigate cancer, work, insurance, disability coverage, and financial survival. She is the founder and author of When Women Get Sick, a book built from decades inside the legal, workplace, and patient advocacy systems most people only discover after diagnosis.Bloom started in Big Law at Simpson Thacher handling employee benefits and compensation work she originally chose to pay off student loans. Then her mother was diagnosed with breast cancer. Suddenly the language she used in corporate law offices became the language of survival at home. Explanation of benefits forms. Coverage disputes. Second opinions. Disability protections. Medical leave. Bills no one could explain.That collision changed the direction of her life.In this episode, Bloom explains how serious illness quietly turns patients into unpaid administrators managing paperwork, logistics, financial risk, and emotional labor while trying to survive treatment. She breaks down how employer based health insurance shapes nearly every aspect of cancer care in America and why women often carry the invisible burden of protecting everyone else from discomfort while they themselves fall apart.The conversation digs into workplace power, the illusion of the healthcare “safety net,” caregiver exhaustion, and the class divide hiding underneath patient empowerment culture. Bloom explains why educated, insured women with resources still struggle to navigate healthcare bureaucracy and what happens to patients without those advantages.This episode explores cancer care, health insurance, employee benefits, patient advocacy, workplace protections, caregiving, and the structural incentives that force sick people to become project managers of their own survival.RELATED LINKSRebecca BloomWhen Women Get SickBay Area Cancer ConnectionsSimpson Thacher & BartlettFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Vasanta Pundarika built her career inside healthcare investment banking before launching Lotuspring, an advisory firm focused on women's health and behavioral health. She spent nearly 20 years advising healthcare systems, treatment providers, and growth stage companies on mergers, financing, and operational strategy while watching the industry repeatedly misunderstand the people it claimed to serve.The conversation starts unexpectedly with anthropology, bread, and language. Vasanta explains how she spent years changing the pronunciation of her own name to make other people comfortable before eventually reclaiming it. That thread opens into a much larger discussion about adaptation, identity, and what institutions quietly train people to tolerate.From there, the discussion moves into behavioral health, women delaying care, and the invisible labor that healthcare business models routinely ignore. During COVID, Vasanta noticed men's behavioral health units refilled faster than women's units. The reason had nothing to do with demand. Women were still home managing caregiving responsibilities, children, aging parents, and households while their own mental health collapsed in the background.The episode examines what happens when healthcare companies become “snazzy big brands” before building real clinical substance underneath. Vasanta describes the tension between mission and margin inside healthcare startups, private equity backed care models, and behavioral health expansion. The conversation pushes on who benefits when healthcare scales aggressively, who absorbs the operational pressure, and how patient trust erodes long before executives notice it on a dashboard.They also discuss patient advocacy culture, anthropology as systems analysis, healthcare capitalism, prior authorization, investor language, and why some clinically excellent companies never survive long enough to scale.RELATED LINKSVasanta PundarikaLotuspringWomen's Health HorizonsSakhi for South Asian SurvivorsNACDPrinceton University Anthropology DepartmentFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

John Gerardi is joined by Jonathan Keller of California Family Council to unpack the disturbing expansion of Canada's euthanasia program, from proposals to euthanize infants with disabilities to recommendations that minors consent to their own deaths without parental input. This week's mystery clip reveals just how far the MAID program has gone, with roughly half of 2024 recipients citing feeling like a burden rather than terminal illness. The guys then break down how activists quietly corrupt language, sliding from physician assisted suicide to medical assistance in dying to simply assisted death, and why that shift matters. Finally, they take on a New England Journal of Medicine article arguing to contextualize the dead donor rule, a euphemism for harvesting organs from euthanasia patients before death, and explain why the slippery slope keeps proving pro-lifers right.

On this episode of The Karol Markowicz Show, Karol sits down with Jonathan Hammel—physician, novelist, composer, and host of the Blood Flow podcast—to discuss his powerful new novel, The Jewish Hospital. Inspired by the real-life experiences of Hamill's grandmother, who served as a nurse in Berlin's Jewish Hospital during World War II, the conversation explores one of history's lesser-known stories: how a Jewish hospital continued operating in Nazi Berlin while doctors, nurses, and patients lived under constant threat of deportation. Jonathan explains how years of research, family interviews, and historical records shaped the novel, while also examining the difficult ethical questions medical professionals faced under unimaginable circumstances. He also discusses why the book is being taught in medical bioethics programs, what modern healthcare can learn from history, and why he believes authentic human creativity will remain essential—even in the age of artificial intelligence.See omnystudio.com/listener for privacy information.

Medical missionaries are often called upon to provide care that is beyond the scope of their training and previous experience. This interactive case presentation looks at the realities of clinical decision-making in a critically ill snakebitten patient, and offers suggestions on how to navigate similar challenging situations.

Brad Power spent years advising major corporations on systems design, process engineering, and decision making before lymphoma shoved him into the patient side of American healthcare. Instead of accepting the experience at face value, he started reverse engineering the machinery around cancer itself. Brad is the founder of Cancer Patient Lab and Open Cancer AI, two projects built around a blunt reality most patients discover too late: the healthcare system rewards people who know how to navigate it. Everyone else risks getting steamrolled by information asymmetry, insurance barriers, administrative friction, and institutional incentives designed around efficiency instead of human survival.The conversation starts with Harvard Business Review and Tumblr blogs before moving directly into the darker architecture underneath modern cancer care. Power explains how hospitals optimize for throughput, how insurance companies reward operational consistency over personalized medicine, and why many patients quietly end up needing a crash course in oncology, reimbursement policy, and behavioral psychology while fighting for their lives.The discussion digs into CAR-T therapy, functional testing, AI assisted decision support, and the growing collision between personalized medicine and standardized care pathways. Power argues that engaged patients often get better outcomes because they learn how to push for off guideline treatments, contest denials, and ask smarter questions. The counterpoint lands hard: patients should never have needed to become experts in the first place.The episode also explores the cultural consequences of AI entering cancer care. OpenAI advertising, data privacy, trust erosion, pharmaceutical influence, and “agentic AI” all collide inside a healthcare economy already drowning in distrust. Power sees artificial intelligence as a force multiplier for patient literacy and access. The larger system still decides who gets approved, who gets delayed, and who gets left behind.By the end, the conversation lands exactly where modern healthcare keeps forcing people to land: survival increasingly depends on learning how the machine works before the machine works on you.RELATED LINKSBrad PowerCancer Patient LabOpen Cancer AIHarvard Business ReviewResearch to the PeopleCAR T Cell TherapyFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Learning Leader Show with Ryan Hawk www.LearningLeader.com New Book - The Price of Becoming - www.LearningLeader.com/Becoming This is brought to you by Insight Global. If you need to hire one person, hire a team of people, or transform your business through Talent or Technical Services, Insight Global's team of 30,000 people around the world has the hustle and grit to deliver. My guest: Ezekiel J. "Zeke" Emanuel, MD, PhD, is a prominent oncologist, bioethicist, and health policy expert. Currently Vice Provost for Global Initiatives at the University of Pennsylvania, he was instrumental in shaping the Affordable Care Act and served as the founding chair of the Department of Bioethics at the National Institutes of Health. Key Learnings Zeke's dad was called "Speedy." He was a Chicago pediatrician who worked 24-hour call, walked so fast the nurses had to run to keep up, and had a rule: the fourth child in any family was free. He recognized the financial strain on families and just wouldn't charge. Zeke's mom was the definition of the anti-helicopter parent. At the playground, she sat on the bench. At the beach, she dropped the boys off with a blanket and a snack. "You go play. Something goes wrong? Okay, that's how it goes." That's how three future powerhouse leaders learned to negotiate, create, and figure it out. The Emanuel brothers' group text is full of bragging. Zeke posted his 51.9 VO2 max score at 68 years old, asking, "Do I win in the family?" His kids replied that they don't even read the articles Zeke and Rahm forward anymore. Close doesn't mean uncompetitive. A dozen years ago, Zeke wrote his most famous article, "Why I Hope to Die at 75." He still stands by it. The point wasn't that he wants to die. The point is that after 75, he won't take medical treatments meant to prolong life.  By age 75, 30% of adults have Alzheimer's or cognitive impairment. By 80, it's 40%. Zeke doesn't want to be remembered as a doddering old man who can't recognize his own family. Living a long time is a means, not an end. It's not the goal of life. It's what allows you to be present, engaged, and useful for the years you have. Biohacking is a lie: It suggests you know better than millions of years of evolution and the entire medical profession. The body isn't about maxing. It's about balance. Too much immune response gives you autoimmunity. Too little makes you sick. The body finds health in the median. You're not going to be perfect over decades. Wellness isn't a four-minute figure skating routine graded on execution. It's a lifetime practice. So build habits you enjoy and can sustain without thinking about them. Zeke's six simple rules for a long and healthy life: Don't be a schmuck. Avoid activities riskier than driving. Smoking, vaping, base jumping, climbing Everest. Talk to people. The number one predictor of a long, happy life. Expand your mind. Travel. Talk to the chef. Learn something new. Eat your ice cream. Moderation over perfection. Fermented foods and fiber. Move. Aerobic, strength, and flexibility. All three. Sleep like a baby. You can't will it. But you can create the conditions. The Harvard Adult Development Study followed people for 85 years. John F. Kennedy was in it. Ben Bradlee was in it. The finding: close friends and being married correlated with the healthiest, longest, happiest lives. Not exercise. Not diet. Relationships. Having no close friends is equivalent to smoking 15 cigarettes a day. That's how bad loneliness is for you. It's not just psychological. It's physical. Introverts get the same happiness boost from social interaction as extroverts. A University of Chicago study by Nicholas Epley found that introverts assume they won't enjoy talking to strangers on their commute. They were wrong. When they did it, they were just as happy as extroverts. Take the headphones off. Zeke has been telling people this since the iPod era. Random encounters increase your surface area for luck, learning, and connection. You never know who you're going to meet or what they might tell you. To be interesting, you have to be interested. Zeke asks to meet the chef at every great restaurant. He asks his Ethiopian Uber driver which tribe he's from. He talks to the person on the plane. It's virtuous. Good for you AND good for them. Zeke's hero is Ben Franklin. Franklin came back to America at 80 after negotiating the end of the Revolutionary War. The first thing he did was build a library for his curiosity and a dining room for his social dinners. That's the way to live. The wellness trifecta: hosting a dinner party with curious people. You're eating good food. You're getting together with people. Your mind is being stretched by great conversation. Three benefits from one activity. Zeke is anti-wellness-industrial-complex. Peptides from your corner store: disaster, unregulated, no idea what's in them. Testosterone replacement therapy without a real deficiency: bad idea, accelerates prostate cancer. Growth hormone for aging: promotes cancers. That's being a schmuck. Sleep is the one wellness practice you can't will yourself into. You can only build the conditions for it. Dark room. Cool temperature. No caffeine or alcohol eight hours before bed. Phone in another room. Read a book. Everything else is up to your body. Ice cream actually decreases your risk of type 2 diabetes. The fat content softens the glycemic response. Plus, you usually eat it with other people. Social eating matters. Zeke's champagne moment a year from now: finishing his next book on how to fix the American healthcare system, and turning 70. Reflection Questions Are you optimizing for length of life, or for the quality of years you actually get?  When was the last time you turned your headphones off, introduced yourself to a stranger, or asked to meet the chef?  Who are the friends you rely on for social interaction? Not casual acquaintances, but the ones who lift your health, longevity, and happiness. When did you last make plans with them? More Learning #607 - Dr. Meg Meeker - Raising Resilient Kids (Strong Fathers, Strong Daughters) #690 - Austin Kleon - Why Activated Leaders Win #682 - Will Guidara - Adversity is a Terrible Thing to Waste

Send us Fan MailWe talk with Órla O'Donovan about how medical museums and university heritage spaces can hide violence in the display cabinets while still shaping what we treat as knowledge, normality, and progress. We discuss with the limits of consent, erasing records, and why real repair demands ongoing reckoning with the past. References to topics discussed:Órla O'Donovan, University ‘dude walls' must fall, Community Development Journal, Volume 60, Issue 1, January 2025, Pages 13–17, https://doi.org/10.1093/cdj/bsae050 O'Donovan, Órla. "“The Irish giant” and the questions haunting medical museums." bmj 381 (2023). Tasmania government apologises for display of autopsy body parts in museum without consentVial episode over after precious blood comes home to Elcho IslandUndisciplinary - a podcast that talks across the boundaries of history, ethics, and the politics of health. Follow us on Twitter @undisciplinary_ or email questions for "mailbag episodes" undisciplinarypod@gmail.com 

By the time the paper hit version 71, Dr. Nirosha Murugan had already done the hard part. The data were real. The experiment had worked. A team of researchers had used a wearable bioreactor to trigger limb regeneration in frogs, a result with obvious implications for regenerative medicine. But the science still wasn't getting over the line. The problem wasn't the work. It was the translation.On this episode of Standard Deviation, host Oliver Bogler talks with Dr. Nirosha Murugan, a biophysicist and Tier II Canada Research Chair in Tissue Biophysics at Wilfrid Laurier University, about what happens when a scientist working at the edges of quantum biology, bioelectricity, and tissue regeneration runs headfirst into the unwritten rules of academic publishing. Murugan's research asks biologists to think beyond molecules and chemistry alone, and to consider the physical signals, electromagnetic fields, and invisible forces that shape development and healing. It is ambitious science. It is also exactly the kind of work that can make gatekeepers nervous.Bogler follows Murugan through the less glamorous part of discovery: the hidden curriculum of getting a paper published, securing scientific credibility, and learning that data do not simply “speak for themselves.” Murugan describes how jargon buried the pitch of her own work, how a lack of editorial support left her at a disadvantage, and how the JEDI program at the Life Science Editors Foundation paired her with a former journal editor who taught her how to structure a manuscript, write a cover letter, and survive peer review.The result was publication in Science Advances, but the larger story is about power. Who gets taught the rules of biomedical research. Who has access to grant writers, editors, and institutional polish. Who is left to brute-force their way through the maze. And how one scientist, having finally found the map, now makes sure her own trainees do not have to learn it the hard way.RELATED LINKSDr. Nirosha Murugan⁠Wilfrid Laurier University⁠Life Science Editors Foundation⁠JEDI Program⁠Science Advances paper on limb regeneration⁠FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Heather Zeiger of Center for Bioethics and Human Dignity talks about the "spud" cell created by scientist at the University of Minnesota that can divide and reproduce itself, well kinda.  Is it really "alive?" Also, she delves into the science behind soccer, plus what happened in Venezuela that caused the earthquakes.  Licensed counselor Debra Fileta of the Talk to Me, author of "People Skills," talks about how empathy is important in understanding others, even those who may have hurt you.  While certain behaviors should not be excused, they can at least be understood where they came from.  The Reconnect with Carmen and all Faith Radio are made possible by your support. Give now: Click here

Dr. Jess Peatross trained in conventional medicine and worked as a hospitalist before she started questioning why so many chronically ill patients kept getting worse inside the healthcare system she trusted. Her perspective carries weight because she spent years following every protocol exactly as taught before walking away from hospital medicine entirely.Raised in Huntington, West Virginia during the opioid crisis, she entered medicine believing the system existed to heal people. Instead, she found hospitals driven by billing codes, liability management, and pharmaceutical dependence while patients with chronic illness, autoimmune disease, mold exposure, and chronic pain cycled endlessly through appointments and prescriptions.Dr. Peatross explains what pushed her toward functional medicine, cannabis therapy, and prevention focused care after watching patients improve only after leaving conventional treatment pipelines behind. The conversation tackles physician burnout, chronic illness stigma, healthcare incentives, and the growing collapse of trust between patients and institutions.The discussion also moves into supplements, environmental toxins, ultra processed food, and the uncomfortable economics behind keeping people permanently sick but continuously billable. Dr. Peatross describes the professional backlash that comes with challenging medical orthodoxy while Matthew connects her experience to the broader erosion of public trust across American healthcare.Together they unpack what happens when patients stop believing the system can help them and start searching elsewhere for answers.RELATED LINKSDr. Jess PeatrossInstagramMarshall UniversityBrave New WeedFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

AI and Generative Biology: Authoring Life, Redesigning Healthcare, and Building Guardrails: Physician and molecular biologist Dr. Adrian Woolfson, co-founder of Genyro, a biotechnology company specializing in synthetic genome design and construction, and author of “On the Future of Species: Authoring Life by Means of Artificial Biological Intelligence,” discusses the convergence of AI with synthetic/generative biology that could make biology programmable and enable genome design and construction beyond traditional gene editing. Woolfson argues that the technology is morally neutral but is arriving rapidly and requires public awareness, governance, and guardrails due to risks, including misuse by authoritarian regimes and biological warfare. He discusses evolution's trade-offs and why he favors limiting human applications to curing disease and extending healthy longevity, while opposing germline modification; he explains germline vs somatic editing and cites the flawed, unethical case of a Chinese scientist attempting inherited HIV resistance. They examine sickle cell disease cures costing $2–$3 million, scalability issues, and trade-offs like malaria protection, and highlight non-medical benefits such as engineered crops, biomaterials, desalination, and DNA-based information storage.

playing god? presents… "A World Without Nurses"—it's a future no one wants to imagine, but doing so brings into sharp focus just how essential nurses are today. Prepare to be transported into this dystopian scenario through innovative storytelling and immersive sound design, ultimately serving as a call to action.Want to help make an impact? Explore our listening session facilitation guide: nursing.jhu.edu/faculty-research/research/centers/r3/a-world-without-nurses/"A World Without Nurses" is an original production by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics, made in association with Maryland's R3: Resilient Nurses Initiative. Written and Produced by Simon Adler. This production features:Sterling A. Wilmer, BSN, RN, BADiane Couchman, MBA, BSN, RNSharon A. Adamski, MSN, RN, CMSRNTamara Hill, DNP, RN, CPNP-ACRachel Robinson, BSN, RN, CCM, DNP-STyler Silvey, BS, ADN, RNLauren Geiling, BS, ADN, RNCaitlin McGeehan, BSN, RN, CHPN, CCRNDanielle McCamey, DNP, RN, ACNP-BC, FCCP, FADLN, FAANThis production is supported by the Nurse Support Program II grant administered by the Maryland Higher Education Commission and funded through the Health Services Cost Review Commission.We'd love to hear about your listening experience! It'd be very helpful to us. To do so, please visit this form: nursingjhu.qualtrics.com/jfe/form/SV_295dYZbajgm08T4For any further inquiries, please contact R3inquires@jh.edu

Farla Efros is a senior retail executive and former CEO who built and sold companies before facing her own breast cancer diagnosis. She brings that same operational mindset into a healthcare system that expects patients to manage complexity while they are at their most vulnerable.She was on a client call in Spain when the diagnosis came through. A clear mammogram had missed it. An MRI caught it. Within hours, she was ordering binders, building a plan, and structuring her treatment like a turnaround strategy. Every appointment became a meeting. Every doctor faced an agenda with dozens of questions. She paid out of pocket for PET scans that were denied and hired a third party firm to validate her treatment path when her own doctors resisted outside input. The conversation tracks what happens when a high-functioning executive enters a system built on delay, denial, and fragmentation. Efros describes negotiating for tests, managing physician relationships, and assembling an “executive board” of advisors across conventional and alternative care. She calls the experience “the worst client I ever had,” exposing how administrative burden shifts onto patients and families.The tension sits between what worked for her and what is inaccessible to most. Her approach requires confidence, time, and fluency in navigating power. The system rewards that behavior while quietly failing patients who cannot replicate it. Insurance coverage still left her paying out of pocket. Doctors pushed standard protocols over precision medicine. Survivorship offered little support once treatment ended.This episode examines how cancer care operates as a series of incentives rather than a coordinated system, and why patients are forced to become operators just to get through it.RELATED LINKSFarla EfrosFarla Efros on LinkedInF*ck CancerF*ck Cancer on AmazonAccentureCTOAMPULL QUOTES“I treated cancer like the worst client I ever had.”“They wouldn't approve the test, so I paid for it myself.”“Every appointment was a negotiation.”FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The iDeas Lab team is hard at work on playing god? Season 3, but we have some special things to share with you in the meantime. Listen for a preview of what's coming next in the feed. And we're opening a voicemail box! Call us at 410-417-9860 to tell us your questions, reactions, and stories. We look forward to hearing from you. 

About this episode:   Research on the potential impacts of certain medications, vaccines, and interventions on pregnant people and their fetuses is lacking. Much of this is due to culturally perceived risks associated with pregnancy and fears of litigation. In this episode: Ruth Faden, an expert in bioethics, explains how this gap in data can fuel other risks and how to ethically and responsibly include pregnant people in clinical trials. Note: This conversation builds on a recent episode of playing god?, the podcast from the Johns Hopkins Berman Institute of Bioethics. Listen to that episode here. Guest:  Ruth Faden, PhD, MPH, is the Philip Franklin Wagley Professor of Biomedical Ethics and the founding director of the Johns Hopkins Berman Institute of Bioethics.  Host:  Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs.  Show links and related content:  Two Bodies, One Prescription—playing god? COVID-19 Vaccines and Pregnancy—Johns Hopkins Bloomberg School of Public Health The second wave: Toward responsible inclusion of pregnant women in research—International Journal of Feminist Approaches to Bioethics Weighing the Risks and Benefits of Medication Use During Pregnancy—Public Health On Call (October 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In 2020, Emily Mendenhall drove from Washington, DC to Okoboji, Iowa, a town of 800 that swells to 200,000 every summer, and walked into a pandemic that looked nothing like the one dominating national headlines. Inside gas stations and bars, masks marked you as an outsider. In one stop, a man told her family they would not be served if they kept theirs on. Her 6 year old daughter cried, confused. Mendenhall, a medical anthropologist at Georgetown University, did what she always does. She started asking questions. Over months, she interviewed neighbors, former classmates, and local officials, including her own brother in law who helped lead the local COVID response. The result became Unmasked, a case study in how community identity, economics, and politics shaped public health decisions in real time. That work led directly into her latest book, Invisible Illness: A History, from Hysteria to Long COVID, where she tracks a much older problem. Patients with chronic illness, especially women, often fail to meet medicine's demand for proof. Without a clear diagnosis, they lose access to care, insurance coverage, and legitimacy. Mendenhall argues that long COVID did not create this failure. It exposed it.This conversation centers on how healthcare systems reward certainty and punish complexity. Long COVID clinics send patients to 17 specialists without resolution. Insurance structures require diagnoses that many conditions cannot provide. Medical training still struggles to integrate trauma, mental health, and chronic disease into a coherent model of care.Mendenhall brings lived experience into the conversation. After COVID, she dealt with months of fatigue and escalating anxiety that altered her baseline health. She does not claim the label of long COVID, but she understands how quickly the system becomes harder to navigate once symptoms stop fitting clean categories. The stakes are not theoretical. In the United States, access to healthcare, disability benefits, and treatment still depends on whether a condition can be measured, coded, and reimbursed. For millions living with invisible illness, the burden of proof becomes the illness itself.RELATED LINKSEmily MendenhallInvisible Illness: A History, from Hysteria to Long COVIDScience PoliticsGeorgetown UniversityFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As Christians, we need to stay informed about the rapidly changing world of fertility treatments, genetic testing, and IVF before making decisions or forming opinions. Join C.L. as we explore the powerful story behind the Boozer family, wrestle with difficult questions about life, embryos, technology, and God's will, and seek biblical wisdom for navigating one of the most important ethical conversations of our time.

When Ashley Womble decides she wants to start a family, she worries she'll need to stop taking her antidepressant medication. Instead of finding clear guidance, she runs head-first into a troubling reality: many of the questions pregnant women and their physicians face about medication safety remain difficult to answer because pregnant women have historically been excluded from medical research. This episode looks at the ethical trade offs of leaving pregnant women out of medical research—and what happens when they and their doctors must make high stakes healthcare decisions without high quality evidence.This episode features:Ashley Womble, MPH: Writer and marketing professional.Ruth Faden, PhD, MPH: Philip Franklin Wagley Professor of Biomedical Ethics at the Johns Hopkins Berman Institute of Bioethics.Crystal Clark, MD, MSc: Associate Professor, Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto.Marika Toscano, MD, MS: Assistant Professor of Gynecology and Obstetrics at Johns Hopkins University School of Medicine.This episode contains references to suicide, which may be distressing for some listeners. If you or someone you know is struggling, support is available.In the U.S., you can call or text the Suicide and Crisis Lifeline at 988 or the National Maternal Mental Health Hotline at 1-833-TLC-MAMA.For listeners outside the U.S., the International Association for Suicide Prevention can help connect you with support in your area: www.iasp.info/suicidalthoughts/“playing god?” is a podcast by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. To read a transcript of this episode, visit the iDeas Lab website at https://bioethics.jhu.edu/pgs2e6.The Johns Hopkins University Sesquicentennial is proud to support this podcast. JHU celebrates 150 years of pioneering education and research—advancing knowledge to meet the challenges of every generation. Learn more at 150.jhu.edu.

Host Dr. Mike Chupp is joined by CMDA's Vice President of Advocacy & Bioethics, Dr. Brick Lantz, to answer listener questions from both CMDA members and non-members. Together, they cover a wide range of topics, including conscience protections for pharmacists, the collision of faith and culture in the exam room, caring for patients who are dying, and the spiritual disciplines that help keep Christian healthcare professionals grounded.

Wesley J. Smith of the Discovery Institute Wesley Smith’s National Review Columns Culture of Death: The Age of “Do Harm” Medicine Forced Exit: Euthanasia, Assisted Suicide and the New Duty to DieThe post A Bioethics Update – Wesley Smith, 6/16/26 (1673) first appeared on Issues, Etc..

At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Rebecca Morrison is healthy by many measures. But like millions of people today, she finds herself wondering whether or not she should be taking a GLP-1 drug. What's the right thing to do? This episode explores how this new class of weight loss drugs is reshaping our healthcare choices, and the landscape in which we make them.You can read more about Rebecca Morrison's story in her novel, The Blue Dress, released March 2026. This episode features:Rebecca K. Morrison: Writer.Mara Gordon, MD: Primary Care Physician at Cooper University Hospital and Assistant Professor of Family Medicine at Cooper Medical School of Rowan University.Alexandra Brewis, PhD: Regents Professor and President's Professor at the School of Human Evolution and Social Change at Arizona State University.Jeffrey Kahn, PhD, MPH: Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics.“playing god?” is a podcast by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. To read a transcript of this episode, visit the iDeas Lab website at https://bioethics.jhu.edu/pgs2e5.The Johns Hopkins University Sesquicentennial is proud to support this podcast. JHU celebrates 150 years of pioneering education and research—advancing knowledge to meet the challenges of every generation. Learn more at 150.jhu.edu.

In this Ask Me Anything episode — recorded from memory after the questions were accidentally deleted — Dr. Will Cole and his team answer listener questions on candida overgrowth, body odor as a gut-skin axis check engine light, and Alpha-Gal syndrome. They cover the rotating antifungal approach, the microbiome-body odor connection from a 2017 study, and how ear acupuncture showed 96% symptom relief for Alpha-Gal in a small clinical trial. The conversation also lands on a jaw-dropping Bioethics journal article suggesting scientists should intentionally bioengineer ticks to give humans Alpha-Gal syndrome as an environmental strategy to reduce red meat consumption. Plus Sip of the Summer round two: LaCroix Sunshine, a Costa Rica orange espresso, and organic black iced tea. For all links mentioned in this episode, visit www.drwillcole.com/podcast.Please note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:Refresh your wardrobe with Quince. Go to Quince.com/willcole for free shipping and 365-day returns. Now available in Canada, too.Go to http://bioptimizers.com/willcole and use my exclusive code WILLCOLE to get 15% off any order.Use code WILLCOLE for an extra 30% off at blissy.com/WILLCOLE!To learn more and get 20% off your order, visit ActiveSkinRepair.com and use code: WILLCOLE . You can also find Active Skin Repair on Amazon and at your local CVS.Go to lyma.life and use code WILL10 for 10% off the LYMA Laser.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Attorney Nicolena Nino-Rosato has a unique and diverse background. Having started her career in the District Attorney's office while completing her master's degree In Healthcare Ethics and Bioethics, she understands all sides of a criminal case. She graduated Summa Cum Laude from Washington and Jefferson University in 2005. She then earned her joint JD/MA at Duquesne University and in 2008 Nicole went on to complete her residency program for her PhD at Duquesne University at Mercy Hospital. After working for a large firm in downtown Pittsburgh, Attorney Nino furthered her education by attending Saint James School of Medicine, to which she attributes her ability to grasp difficult medical concepts that come up in her cases. We also have with us co-Founder Timothy Rosato of an app called The NotME App. In episode 682 of the Fraternity Foodie Podcast, we find out common legal situations that college students find themselves in unintentionally, why communication is so complicated today, what was the inspiration behind The NotME App, healthy ways that college students can communicate their boundaries, how technology has changed the way college students communicate, what role alcohol plays in clouding communication, what is Title IX, how fraternities and sororities can create consent cultures in college, and how being a parent changes the way you think about student safety. Learn more about the app at: https://www.thenotmeapp.com

At 20 years old, newly arrived from Puerto Rico and trying to build a future in science, Benjamin Suarez Jimenez found himself sitting in front of two senior faculty members accused of plagiarism. He knew the material. He had done the work. His mistake came from failing to cite class notes during an exam because nobody had told him that was expected. In a matter of minutes, he watched what felt like his entire career flash before him.On this episode of Standard Deviation, host Oliver Bogler examines the hidden architecture of academic science through the experiences of Dr. Benjamin Suarez Jimenez, Assistant Professor at the University of Rochester and a neuroscientist studying PTSD, anxiety, trauma, and spatial cognition through virtual reality and video game environments.Benjamin traces his path from Puerto Rico to the mainland United States, through the NIH, Columbia University, and eventually to leading his own laboratory. Along the way, he encountered a series of barriers that had little to do with scientific ability and everything to do with access to unwritten rules. From academic gatekeeping to grant writing expectations, he learned that success in biomedical research often depends on knowledge that never appears in a textbook.Oliver explores how those invisible obstacles shape careers, influence research funding, and determine who gains access to opportunity. The conversation also examines the Justice, Equity, Diversity, and Inclusion Program at the Life Science Editors Foundation, which pairs scientists from underrepresented backgrounds with experienced scientific editors. Through that mentorship, Benjamin transformed a critical grant proposal into a successful pilot award that helped launch an NIH R01 application.The discussion extends beyond one scientist's experience. Benjamin describes helping a former mentee navigate dissertation roadblocks that threatened her graduation, illustrating how institutional bureaucracy can delay careers and discourage talented researchers. Together, they explore the hidden administrative burden, cultural barriers, and bias that many scientists carry alongside their research, and what happens when someone who receives support turns around and opens the door for others.RELATED LINKSLife Science Editors FoundationBenjamin Suarez Jimenez LabDr. Benjamin Suarez JimenezBenjamin Suarez JimenezFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After 144 years the tallest tower on the Sagrada Familia is finally complete, but when Gaudi first designed it, the technology to build the tower didn't exist. We're joined by Tristram Carfrae, structural engineer and designer at Arup who was tasked with this impossible feat over a decade ago. With the reappearance of screwworm in North America, we ask – is it ever acceptable to intentionally drive a species to extinction? Tom is joined by Dr Gregory Kaebnick from the Hastings Center for Bioethics to dive into the science that could make it happen and the ethics stopping us. Four in five of us will check the weather daily, but do we really know what our apps are telling us? Meteorologist Simon King guides us through the complex models behind these forecasts that govern our daily decisions. Plus, science journalist Caroline Steel is in the studio bringing us the scientific discoveries the headlines missed, but that you need to know. Presenter: Tom Whipple Producer: Kate White Editor: Martin Smith Production Co-ordinator: Jana Bennett-Holesworth

What does it mean to practice pure unlimited love? Love research defines pure unlimited love as a state in which the security and well-being of another becomes as real and meaningful to you as your own. Embracing this mindset is a profound pathway to discovering lasting inner peace. At the heart of this approach is the activation of the ten distinct forms of love that allow us to engage with our modern, enraged culture. By applying the science of altruism, we can look past the anger and actively transform conflict into a deep, authentic connection.. To unpack the science of altruism, Harvesting Happiness Podcast host Lisa Cypers Kamen welcomes Stephen G. Post, the Founding Director of the Center for Medical Humanities, Compassionate Care, and Bioethics at Stony Brook University Renaissance School of Medicine. Stephen breaks down the ten core principles of love from his book, Pure Unlimited Love: Science and the Seven Paths to Inner Peace. He also explores the concepts of care-frontation, Adverse Childhood Experiences (ACEs), and love as the ultimate reality. Like what you're hearing? WANT MORE SOUND IDEAS FOR DEEPER THINKING? Check out More Mental Fitness by Harvesting Happiness bonus content available exclusively on https://harvestinghappiness.substack.com/ and https://medium.com/@HarvestingHappiness.

In this episode, we speak with Dr. Daniel Fogal, Assistant Professor of Bioethics at NYU GPH, about his course Advanced Introduction to The Ethics of Technology. Dr. Fogal shares his journey from a philosophy undergraduate degree to joining the NYU Center for Bioethics, mapping how the discipline has expanded beyond traditional doctor-patient relationships and research ethics to address broader population-level challenges. We dive into complex global issues, including the allocation of scarce medical resources and the modern ethical implications brought on by the rise of social media and artificial intelligence self driving vehicles. Dr. Fogal discusses his passion for teaching applied, controversial issues in the classroom, explaining how he leverages the diverse perspectives of his students to help them think more clearly, carefully, and critically. This conversation highlights NYU GPH's unique interdisciplinary expertise and teaching excellence, showing how grounding public health issues in ethical frameworks equips students to navigate tomorrow's scientific and technological challenges. To learn more about the NYU School of Global Public Health, and how our innovative programs are training the next generation of public health leaders, visit http://www.publichealth.nyu.edu.

Hour 1 for 6/10/26 Drew and Father Tad Pacholczyk discuss DNA editing and cloning (5:22). Topics/calls: epigenetics (14:03), cloning (20:27), personality of clones (22:26), and review boards (25:02). Then, Steve Mosher from the Population Research Institute discusses falling fertility rates (33:57). Topics: why young people don't want children (38:00), socialization (43:30), and the economy (48:31). Links: https://www.ncbcenter.org/ http://fathertad.com/ https://www.pop.org/

Michael Shermer speaks with Oxford philosopher Carissa Véliz about the long human desire to know the future—from ancient oracles and astrology to AI, surveillance capitalism, predictive policing, and "data-driven" decision-making. Véliz argues that prediction is rarely neutral: the same machinery that collects personal data also tries to forecast behavior, and once institutions start treating predictions as facts, forecasts can become tools of control. The conversation gets into why privacy matters for democracy, how algorithms can turn human lives into self-fulfilling prophecies, and why extraordinary people often fall outside predictive models. Shermer and Véliz also discuss the limits of science, the replication crisis, crime statistics, effective altruism, utilitarian ethics, and free will. Carissa Véliz is an associate professor at the Institute for Ethics in AI at the University of Oxford. Her first book, Privacy Is Power (Melville House) was an Economist book of the year and has been published in seven languages. Her academic work has been published in The Harvard Business Review, Nature, AI & Society, and The American Journal of Bioethics, among others. Her new book is Prophecy: Prediction, Power, and the Fight for the Future, from Ancient Oracles to AI.

Dr. Sarah Matt trained as a burn surgeon, working in a field where patients arrive with catastrophic injuries and survival depends on speed, skill, and resources. She left the bedside after confronting a limit that medicine does not like to admit. One physician can only see so many people in a day. The system surrounding those patients decides the rest. She moved into health technology, held leadership roles in startups, and built global infrastructure at Oracle to scale care across populations. Then she watched billions of dollars in digital health and AI initiatives stall out when they hit real clinical environments.This episode follows that pivot from surgeon to strategist and back into direct patient care in rural New York, where she now treats uninsured patients, migrant workers, and communities pushed to the margins. The conversation centers on a persistent failure across healthcare systems. Products get built for regulators, executives, and investors instead of the people who use them. The result shows up in failed adoption, broken workflows, prior authorization delays, and rising physician burnout.The discussion cuts through health policy language and lands on lived consequence. The system rewards speed over usability, scale over trust, and compliance over care. Patients absorb the fallout. Physicians carry the liability. The incentives remain intact.RELATED LINKSDr. Sarah MattThe Borderless Healthcare RevolutionThe Clinical RealistJessica FedererSovatoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After losing their son Noahto to mitochondrial disease, Kristelle and Evan Shulman are determined that his death will not be in vain, holding fast to their dream of having healthy, biologically-related children. This search leads them abroad in pursuit of an emerging reproductive technology, one filled with scientific promise, but also ethical questions, financial strain, and profound uncertainty. This episode explores how families and physicians make decisions when novel approaches can reduce risk, but never eliminate it. (Part 2 of 2.)This episode features:Kristelle and Evan Shulman: Parents navigating mitochondrial disease and reproductive decisionmaking.Marni Falk, MD: Attending physician and Executive Director of the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia and Professor in the Division of Human Genetics, Department of Pediatrics at the University of Pennsylvania Perelman School of Medicine.Jeffrey Kahn, PhD, MPH: Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics.“playing god?” is a podcast by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. To read a transcript of this episode, visit the iDeas Lab website at https://bioethics.jhu.edu/pgs2e4.The Johns Hopkins University Sesquicentennial is proud to support this podcast. JHU celebrates 150 years of pioneering education and research—advancing knowledge to meet the challenges of every generation. Learn more at 150.jhu.edu.

Dust off your aprons and heat up your cast iron because it's finally time for one of our most requested episodes yet! In this episode, Hannah and Marcelle dig deep into the tradwife phenomenon. Using the viral tradwife influencer Ballerina Farm as a case study, Hannah leads us through a discussion about eugenics, replacement theory, and clean living movements. They also get into influencer culture, the performance of farm life, and…milk. Whew! That's a lot, and it's ALL relevant.This episode is for those of you who love to hate tradwives, are curious about their meteoric rise in popularity over the last few years, or have never even heard of them!Related listening:9 to 5 x Labour Feminism with Zena SharmanGet Out x Horrifying WhitenessWitch, Please: Book 7, Ep. 6 | EugenicsWorks Cited:Agnew, Megan. “Meet the queen of the ‘trad wives' (and her eight children.” The Times 20 July 2024: https://archive.ph/YHB08. “Clean living movement.” Wikipedia. https://en.wikipedia.org/wiki/Clean_living_movement. Accessed 14 May 2026. Elster, N., Parsi, K., & Caplan, A. Guest editorial. “Laundering Public Health: Using Autism to Revive Eugenics.” The American Journal of Bioethics (2026): 1–3. https://doi.org/10.1080/15265161.2026.2659519. “Eugenics and Scientific Racism.” National Human Genome Research Institute 18 May 2022. https://www.genome.gov/about-genomics/fact-sheets/Eugenics-and-Scientific-Racism. Accessed 14 May 2026. Luse, Brittany. “Mormon Moms: Unpacking a national obsession.” It's Been A Minute (NPR) 12 November 2024: https://www.npr.org/transcripts/1212541651. Moskin, Julia. “Tycoon or Tradwife? The Woman Behind Ballerina Farm Makes Her Own Path.” The New York Times 3 December 2024: https://archive.ph/Q9j2J#selection-489.0-489.70. Petersen, Anne Helen. “The Edenic Allure of Ballerina Farm.” Culture Study 10 February 2022: https://annehelen.substack.com/p/the-edenic-allure-of-ballerinafarm. Sykes, Sophia and Dr Veronica Hopner. “Tradwives: The Housewives Commodifying Right-Wing Ideology.” Global Network on Extremism & Technology 7 July 2023: https://gnet-research.org/2023/07/07/tradwives-the-housewives-commodifying-right-wing-ideology/. Valverde, Mariana. The Age of Light, Soap, and Water: Moral Reform in English Canada, 1885-1925. Toronto: McClelland & Stewart, 1991.***To learn more about Material Girls, head to our Instagram at instagram.com/ohwitchplease! Or check out our website ohwitchplease.ca. We'll be back next week with a Material Concerns episode, but until then, go check out all the other content we have on our Patreon at Patreon.com/ohwitchplease! Patreon is how we produce the show and pay our team!Material Girls is a show that makes sense of the zeitgeist through materialist critique* and critical theory! Each episode looks at a unique object of study (something popular now or from back in the day) and over the course of three distinct segments, Hannah and Marcelle apply their academic expertise to the topic at hand.*Materialist Critique is, at its simplest possible level, a form of cultural critique – that is, scholarly engagement with a cultural text of some kind – that is interested in modes of production, moments of reception, and the historical and ideological contexts for both.Music Credits:“Shopping Mall”: by Jay Arner and Jessica Delisle ©2020Used by permission. All rights reserved. As recorded by Auto Syndicate on the album “Bongo Dance”.Hosted on Acast. See acast.com/privacy for more information. Hosted on Acast. See acast.com/privacy for more information.

In the late 1980s, a child exposed to fallout from the Chernobyl disaster lay in a hospital bed while doctors told his family there were no clear answers and no reliable path forward. Decades later, that same child, Yan Leyfman, walks into exam rooms as a hematology oncology fellow, expected to deliver clarity inside a system that still runs on delay, uncertainty, and institutional self preservation.This episode traces the throughline from early life shaped by radiation exposure and hospice level uncertainty to a career inside academic medicine, translational research, and oncology media. Yan built his identity around survival and usefulness, moving from patient to physician while carrying the memory of what it feels like to sit on the other side of the table. He helped launch MedNews Week during the COVID crisis to push back on misinformation and expand access to medical knowledge, stepping into a public role while still in training.The conversation stays grounded in the friction between personal narrative and system reality. Clinical training demands efficiency, hierarchy, and emotional distance. Cancer care demands time, clarity, and human connection. Those forces collide in real patient encounters where prior authorization delays, insurance barriers, and fragmented care pathways shape outcomes as much as any treatment protocol.Yan speaks openly about mentorship, belonging, and the drive to make meaning out of survival. The discussion pushes further into what the healthcare system actually rewards, what it quietly strips away, and how quickly empathy can erode under institutional pressure. The episode also examines the role of medical media, where education, industry influence, and narrative control often blur together.This is a conversation about identity under construction, about what happens when someone who remembers powerlessness steps into a role that carries authority, and about whether that memory can survive long enough to change anything.RELATED LINKSYan Leyfman on LinkedInYan Leyfman on InstagramSurviving ChernobylFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

When Kristelle and Evan Shulman lose their young son Noah to a rare mitochondrial disease, they are told they may never be able to have a healthy biologically related child. Then they discover mitochondrial replacement technology, or MRT, a controversial procedure that could prevent the disease from being passed on to future generations. This episode explores how families, clinicians, and policymakers grapple with the ethics of novel reproductive technologies that offer extraordinary hope amid profound uncertainty. (Part 1 of 2.)This episode features:Kristelle and Evan Shulman: Parents navigating mitochondrial disease and reproductive decision-making.Marni Falk, MD: Attending physician and Executive Director of the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia and Professor in the Division of Human Genetics, Department of Pediatrics at the University of Pennsylvania Perelman School of Medicine.Jeffrey Kahn, PhD, MPH: Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics.“playing god?” is a podcast by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. To read a transcript of this episode, visit the iDeas Lab website at https://bioethics.jhu.edu/pgs2e3.The Johns Hopkins University Sesquicentennial is proud to support this podcast. JHU celebrates 150 years of pioneering education and research—advancing knowledge to meet the challenges of every generation. Learn more at 150.jhu.edu.

Bioethics are a matter of practical, everyday concern for physicians, and other health care providers, especially as medical science continues to advance, opening up new therapeutic possibilities. In this episode of The Lancet Voice, the bioethicist and oncologist, Ezekiel Emanuel, talks about applying bioethics to some of today's most pressing health problems, globally.   Click here to read the full article: https://www.thelancet.com/journals/lancet/article/piis0140-6736(09)60137-9/fulltext

Matthew Zachary is a brain cancer survivor, healthcare advocate, founder of Stupid Cancer and We the Patients, and host of Out of Patients. In April 2026, he returned to the stage at Merkin Hall near Lincoln Center for his first solo public piano concert in almost 22 years while launching his debut book, We the Patients: Understanding, Navigating, and Surviving America's Healthcare Nightmare.What unfolded became far larger than a concert.Over 2 hours, survivors, clinicians, advocates, nonprofit founders, journalists, pharmaceutical sponsors, and healthcare insiders gathered in one room to reflect on 30 years of survivorship, institutional failure, accidental advocacy, and the emotional afterlife of cancer. The evening moved through original piano performances, live chapter readings, and deeply personal conversations about infertility, disability, financial toxicity, insurance denials, grief, burnout, and what happens when patients spend decades navigating systems designed around transactions instead of continuity.Guests including Wendell Potter, Maimah Karmo, Craig Lustig, Shelly Fuld Nasso, Tamika Felder, and others reflected on how the modern cancer advocacy movement emerged largely because patients built parallel systems where healthcare infrastructure failed to meet human needs. The conversation explored how prior authorization, reimbursement incentives, administrative fragmentation, and institutional distrust continue shaping the patient experience across oncology and survivorship.The performance also marked a deeply personal milestone. After brain cancer compromised his left hand at age 21, Zachary spent 6 months rehabilitating both hands to return to public performance for the first time in over 2 decades. The result became part concert, part civic gathering, and part historical record of a generation of survivors who refused to disappear quietly.RELATED LINKSMZLIVE Official WebsiteMZLIVE YouTube VideoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What does it take to build a culture of ethics inside a health system — and what happens when leaders lack the courage to defend it? In this episode of SoundPractice, host Mike Sacopulos sits down with Arthur Caplan, PhD, one of the world's foremost bioethicists and the founding head of the Division of Medical Ethics at NYU Grossman School of Medicine's Department of Population Health. Dr. Caplan traces his path into bioethics from a childhood hospitalization for polio to graduate training at Columbia, where he witnessed firsthand the ethical gaps in medicine's early encounters with IVF, informed consent, and research oversight. That experience shaped a career devoted not just to theorizing about ethics, but to solving real problems in real institutions. In this wide-ranging conversation, Dr. Caplan and Mike Sacopulos explore: - What an effective ethics infrastructure looks like - The defining bioethical challenges of the next decade - Compassionate use and unproven therapies - Misinformation and informed consent - Rationing and equity - Bioethics training for the next generation Learn more about the American Association for Physician Leadership.

In December 1996, a 37 year old pharmaceutical executive sat in a Borders bookstore reading medical textbooks on the floor, trying to understand a disease she had never heard of. Multiple myeloma carried a three year prognosis. Her daughter was 18 months old. Her father had just died of cancer. Within weeks, she pushed her doctors to say the quiet part clearly. This would likely end her life before her child entered kindergarten.Kathy Giusti refused to accept passive survival. She built a plan while the system offered fragments. She interviewed oncologists and fertility specialists at the same time. She pursued IVF to have a second child while preparing for treatment. She stayed employed to keep insurance coverage. Every decision carried financial, medical, and emotional risk.That same urgency exposed a deeper failure. Cancer research moved slowly. Academic centers guarded data. Clinical trials lacked coordination. Patients entered a system that demanded compliance without providing clarity. Giusti responded by building the Multiple Myeloma Research Foundation, not as a support group, but as an operating engine to accelerate drug development, fund research, and force collaboration across institutions.This episode tracks the tension between individual agency and systemic failure. Giusti describes how patients navigate diagnosis, insurance barriers, and fragmented care in real time. She explains how data, genomics, and clinical trials reshape cancer treatment while still leaving patients responsible for decisions they are not trained to make. She addresses disparities in access, the limits of early detection, and the reality that progress in oncology often depends on speed, funding, and alignment of incentives.The conversation moves between lived experience and structural critique. It names the cost of delay, the burden placed on patients to act as their own advocate, and the tradeoffs required to push a system forward that still protects itself first.⸻RELATED LINKSKathy GiustiMultiple Myeloma Research FoundationFatal to FearlessAmerican Society of Hematology⸻FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Humanity is actively working towards a mission to Mars. When astronauts like Bernard Harris leave Earth, they accept risk as part of the mission. But a journey to Mars would push that risk into entirely new territory—where help is unreachable, uncertainty is unavoidable, and coming home may not be an option. This episode explores how space agencies, astronauts, and all of us need to grapple with how much risk is ethically acceptable for individuals to take on in pursuit of societal benefit, and who gets to decide. This episode features:Bernard A. Harris Jr., MD: former NASA astronaut.James D. Polk, DO: Chief Health and Medical Officer of NASA.Jeffrey Kahn, PhD, MPH: Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics.“playing god?” is a podcast by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. To read a transcript of this episode, visit the iDeas Lab website at https://bioethics.jhu.edu/pgs2e2.The Johns Hopkins University Sesquicentennial is proud to support this podcast. JHU celebrates 150 years of pioneering education and research—advancing knowledge to meet the challenges of every generation. Learn more at 150.jhu.edu.

For this episode, we are joined by Kadija Ferryman, an anthropologist who studies equity and policy in health risk prediction technologies. Dr. Ferryman is Faculty at the Berman Institute of Bioethics and Assistant Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health.Dr. Ferryman traces her path into studying technology through a cultural anthropology lens, beginning with an early curiosity about how different cultures define illness and disease. She explains how the cultural anthropology focus on beliefs, values, and power structures shapes the way she examines modern health technologies. Using examples like the sequencing of the human genome, she highlights how different scientific communities drew strikingly different conclusions from the same discovery, revealing deeper tensions about race, biology, and social meaning that continue to influence biomedical research.Building on this foundation, Dr. Ferryman explores how bias becomes embedded in everyday health technologies, from pulse oximeters to clinical risk prediction algorithms. She describes how known inaccuracies of pulse oximeter readings for darker-skinned individuals persisted for decades and became especially visible during the COVID-19 pandemic. Extending these concerns to emerging areas like generative AI, she raises important questions about how biased data can shape both clinical care and healthcare systems more broadly. At the same time, she offers a more nuanced perspective: these flawed technologies can also serve as powerful windows into the inequities of our society and as opportunities to rethink how ethics is integrated into medicine and technological development.Ferryman K, Mackintosh M, Ghassemi M. Considering Biased Data as Informative Artifacts in AI-Assisted Health Care. N Engl J Med. 2023 Aug 31;389(9):833-838.Ethical Guidelines for AI:https://healthaipartnership.org/health-equity-across-the-ai-lifecycle-heaalhttps://www.chai.org/https://nam.edu/our-work/programs/leadership-consortium/health-care-artificial-intelligence-code-of-conduct/Select other publications by Dr. Ferryman:Collins BX, Bélisle-Pipon JC, Evans BJ, Ferryman K, Jiang X, Nebeker C, Novak L, Roberts K, Were M, Yin Z, Ravitsky V, Coco J, Hendricks-Sturrup R, Williams I, Clayton EW, Malin BA; Bridge2AI Ethics and Trustworthy AI Working Group. Addressing ethical issues in healthcare artificial intelligence using a lifecycle-informed process. JAMIA Open. 2024 Nov 15;7(4):ooae108.Shachar C, Drabo EF, Iwashyna TJ, Ferryman K. Addressing Racial and Ethnic Bias in Pulse Oximeters-A Wicked Problem. JAMA. 2025 Feb 18;333(7):563-564.Ferryman K, Crews DC, Drabo EF, Iwashyna TJ, Kane O, Jackson JW. Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024. JAMA. 2025 Feb 18;333(7):631-632Also mentioned on the show: Joy Buolamwini Coded Bias

At 19, Shlomit woke up unable to speak. The right side of her body went numb. An emergency room sent her home and called it stress. That moment did not end in a diagnosis that changed policy or triggered reform. It sent her into a decade long pursuit of understanding how the brain fails language and how the healthcare system fails patients who cannot advocate for themselves.Shlomit trained as a speech language pathologist and spent years inside acute care hospitals and ICUs, performing endoscopies and treating patients with brain injury, stroke, and dysphagia. She watched medical teams rotate in and out, deliver dense updates, and leave families nodding without comprehension. She stayed behind and translated. Every day, patients told her she was the only one who explained what was happening. That gap is not an accident. Hospital systems optimize for throughput, not understanding. Patients move through beds based on cost, not readiness. Discharge planning becomes a financial decision wrapped in clinical language. A stay under 48 hours can shift the insurance burden dramatically, leaving patients exposed to higher out of pocket costs. Shlomit left the system and built Patient Path NYC, a private patient advocacy service. She now spends 15 to 20 hours a week per client reading charts, coordinating care teams, and translating medical decisions into plain language. Her work sits in the uncomfortable space between healthcare policy and lived experience. Families pay out of pocket to understand their own care. Hospitals benefit from the clarity she provides while maintaining the same structural incentives that created the confusion.This conversation tracks the human cost of fragmented care, the economics behind discharge decisions, and the quiet reality that patients who cannot communicate clearly often lose control of their own outcomes.RELATED LINKSShlomit LibertyShlomit Liberty on LinkedInPatient Path NYCBoard Certified Patient AdvocateFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

When journalist Esmé Deprez receives a text from her father, Ron Deprez, asking for help to die, she enters one of the most ethically fraught spaces in modern medicine: Medical Aid in Dying (MAiD). This episode explores what it means to assist a loved one's death under MAiD law—and how personal compassion collides with professional and societal ethics.This episode features:Esmé E. Deprez: Writer and investigative journalist. Jeffrey Kahn, PhD, MPH: Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics.Jennifer Eitingon, MD: Medical Director of Monument Health Hospice and Inpatient Palliative Care Attending Physician.You can see photos and read more about Esmé and Ron Deprez's story in her 2021 essay, “Death With Dignity: How I Helped My Dad Die.” “playing god?” is a podcast by the iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. To read a transcript of this episode, visit the iDeas Lab website at https://bioethics.jhu.edu/pgs2e1 The Johns Hopkins University Sesquicentennial is proud to support this podcast. JHU celebrates 150 years of pioneering education and research—advancing knowledge to meet the challenges of every generation. Learn more at 150.jhu.edu.

In 2020, developmental biologist Dr. Crystal Rogers drove the country roads outside Davis, California crying between grant rejections, wondering whether she was about to lose her lab, her career, and the scientific future she had spent years building. She had already done what academia tells young scientists to do. She earned the credentials. She landed a faculty position at UC Davis. She built a lab. Then the real test began.On this episode of Standard Deviation, Dr. Oliver Bogler examines the unspoken rules that determine which scientists survive academic research and which quietly disappear from it. The conversation follows Crystal Rogers and cancer biologist Dr. Michelle Mendoza as they collide with the “Hidden Curriculum” of biomedical science: the unwritten rhetoric, institutional signaling, and grant writing strategies that often decide who receives funding, tenure, and long term stability.Michelle Mendoza entered a tenure track position at the Huntsman Cancer Institute while raising 3 children, navigating a divorce, and trying to secure major NIH funding during COVID. What looked like objective scientific review turned out to depend heavily on persuasion, presentation, and insider fluency. Established researchers could promise massive research agendas based on reputation alone. Junior investigators faced a completely different standard.Oliver traces how the Life Science Editors Foundation and its JEDI program intervened by pairing scientists with former editors from journals including Cell and Nature. The work had little to do with commas or grammar. Editors challenged logic, structure, and scientific framing before grant reviewers could destroy an application in public.Both researchers eventually secured career defining grants. One realized she would keep her job and not have to move her family. The other celebrated by ordering a personalized “DEV BIO” license plate and driving through Davis blasting nineties hip hop and Beyoncé.The episode exposes how biomedical research funding rewards institutional fluency as much as scientific talent, and how hidden systems inside academic medicine continue shaping who gets to stay in science long enough to make discoveries.RELATED LINKSDr. Crystal Rogers LinkedInDr. Crystal Rogers Faculty PageDr. Crystal Rogers LabDr. Michelle Mendoza LinkedInDr. Michelle Mendoza Faculty PageHuntsman Cancer Institute Mendoza LabLife Science Editors FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In 2008, Katy Talento walked away from Capitol Hill and into a Catholic convent. Within a year, she walked out. Within another decade, she sat inside the White House shaping health policy. Somewhere in between, she got labeled “infertile” after a single cycle of testing and spent years believing it.That label stuck. The pain that came before it never got investigated. Doctors offered birth control and moved on. No one asked why her body was struggling. No one followed the thread.Talento built her career inside the very systems she now critiques. She worked on federal health policy, global disease programs, and later advised the Trump administration on healthcare reform. She helped advance price transparency rules in a system where hospitals can still list 457 different prices for the same service.Then she left.Now she builds employer health plans that bypass insurers, PBMs, and traditional networks. Her approach replaces insurance contracts with direct payment, nurse navigators, and cost sharing models that promise simplicity but raise hard questions about risk and protection.This conversation sits in that tension.Talento describes a healthcare system shaped by layered incentives, where insurers, hospitals, and intermediaries profit from complexity. She argues that employers hold the leverage to disrupt it. The host pushes on what happens when patients fall outside those structures, when contracts disappear, and when community based models fail.The episode moves through infertility, misdiagnosis, insurance design, and the mechanics of employer sponsored care. It tracks how policy decisions made in Washington ripple into exam rooms, billing departments, and family lives.It also confronts a harder truth.Even insiders who understand the system can still get caught in it.RELATED LINKSAllBetter HealthKaty TalentoThem Before UsAn Arm and a LegRelentless Health ValueFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Life and death decisions. Difficult tradeoffs. “playing god?” explores ethical dilemmas in health and medicine through the first-person stories of people who have lived them. Brought to you by the Dracopoulos-Bloomberg iDeas Lab at the Johns Hopkins Berman Institute of Bioethics. New episodes weekly starting May 19. 

In a wooded campground cabin in the early 2000s, 19 year old Ben Unger stood in the doorway and watched 20 naked men form a circle around a crying teenager. A counselor held up two tangerines and shouted, “These are your balls.” The exercise claimed to cure same sex attraction by forcing young men to “reclaim” their masculinity from overbearing mothers. Phones had been confiscated. Parents had paid thousands of dollars. Religion supplied the script. Pseudoscience supplied the props.Ben had grown up in an Orthodox Jewish community in Brooklyn and later studied in Israel to become a rabbi. When he admitted he felt attracted to men, rabbis told him to eat 7 figs a day, immerse in a ritual bath 5 times daily, or marry a woman and trust that “if there's friction, it works.” At 19, he entered conversion therapy through an organization called Jews Offering New Alternatives to Homosexuality, known as JONAH. He left with depression, religious trauma, and 6 months of silence toward the mother he had been taught to blame.Years later, represented by the Southern Poverty Law Center, Ben helped sue JONAH for consumer fraud in a landmark New Jersey case. The argument centered on evidence, not theology. Sexual orientation cannot be changed. The jury deliberated for 3 hours and ruled against the organization. The verdict helped reshape how states regulate conversion therapy and protect minors from psychological harm disguised as treatment.Today, Ben runs Buff Personal Training in New York City, a gym built on autonomy, mental health, and self respect. His story traces the arc from institutional control to self authorship. The conversation examines religion, LGBTQ rights, conversion therapy, consumer protection law, and the lasting cost of being told your identity is a disorder.RELATED LINKSBen Unger on LinkedInBen Unger on InstagramBUF Personal TrainingSouthern Poverty Law CenterJONAHFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

   4 HEADLINE: The Ecological Role and Bioethics of the Independent Dog GUESTS: Jessica Pierce and Mark Bekoff SUMMARY: This segment defines the "universal dog" as a creature that adapts its style and behavior to its specific environmental niche, from deserts to high latitudes. The guests emphasize that dogs retain a "DNA memory" and latent potential for wild behaviors, such as the killing bite, which were largely suppressed by human selection. From a bioethical perspective, this thought experiment reveals that viewing dogs solely as pets is a limited way to understand their true nature. Instead, dogs should be recognized as independent individuals with lives and interests that exist apart from humans. This shift in perspective encourages owners to see their dogs as wild animals with autonomous needs for richness and meaning. 41861